These tools set cookies that store anonymised information about how you got to the site, and how you interact with the site.
In the talks both ourselves and NHS England continued to offer as much flexibility as possible, but despite the intervention of Secretary of State for Health Wes Streeting, the companies did not put ...
Neupulse is a wearable wrist-worn device linked to a mobile phone app, used to treat those over the age of 12. The device delivers low-intensity electrical pulses to the median nerve to reduce tic ...
There is a simple discount patient access scheme for elafibranor. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...
You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...
The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee C. Committee members are asked to declare any interests in the technology being ...
The research, which will be presented to delegates at the ISPOR conference in Barcelona, Spain, examined NICE technology appraisal and highly specialised technologies guidance published between June ...
This procedure should only be done as part of a formal research study, and a research ethics committee needs to have approved its use.
Evidence-based recommendations on endoscopic bipolar radiofrequency ablation for malignant biliary obstruction. This involves using heat energy to unblock the obstruction. This guidance replaces NICE ...
Review and download supporting evidence. Includes the full guideline if available.
Discontinued. Please note that following on from information provided to NICE by the company in January 2022, the appraisal was suspended from NICE’s work programme. As no further information has been ...